Rare diseases
Investigational molecules
Locations
Back to France2 221 clinical trials in Lyon, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Niraparib and Dostarlimab for Children with Recurrent or Hard-to-Treat Solid Tumors
FranceStudy of Eliglustat alone or with imiglucerase in children and adolescents aged 2-17 years with Gaucher disease type 1 and type 3
FranceStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
FranceStudy on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
FranceStudy on the Effect of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Stage III Ovarian Cancer Patients Undergoing Surgery
FranceStudy on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
FranceStudy of Lacutamab Alone or with Chemotherapy for Patients with Advanced T-Cell Lymphoma
FranceStudy of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma
FranceStudy on the Effectiveness and Safety of L19TNF and Dacarbazine for Patients with Advanced or Metastatic Soft-Tissue Sarcoma After Previous Treatments
FranceStudy of dasatinib treatment in children and adolescents with Philadelphia chromosome-positive leukemia who cannot take imatinib or for whom imatinib is not effective
FranceStudy on L19TNF and Doxorubicin for Patients with Advanced or Metastatic Soft Tissue Sarcoma
FranceStudy of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for endometrial carcinoma, bladder cancer, and various solid tumors. Current research explores combination therapies with novel immunotherapy approaches.
Multiple studies are evaluating targeted therapies and immunological approaches for various tumor types.
Groundbreaking research in immune system modulation and infectious disease prevention, including studies on COVID-19 vaccines and immune response in critical conditions.
Focus on developing innovative vaccination strategies and immune system interventions.
Studies addressing long-term health conditions, with particular emphasis on kidney disease, cardiovascular health, and metabolic disorders.
Innovative approaches combining established and experimental treatments for improved patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
